ANONYMOUS: "History of Changes for Study: NCT00783692", 19 June 2014 (2014-06-19), XP093035184, Retrieved from the Internet <URL:https://clinicaltrials.gov/ct2/history/NCT00783692?V_25=View#StudyPageTop> [retrieved on 20230328] (B1)

CLELAND J L ET AL: "A SPECIFIC MOLAR RATIO OF STABILIZER TO PROTEIN IS REQUIRED FOR STORAGE STABILITY OF A LYOPHILIZED MONOCLONAL ANTIBODY", JOURNAL OF PHARMACEUTICAL SCIENCES, AMERICAN PHARMACEUTICAL ASSOCIATION, WASHINGTON, US, vol. 90, no. 3, 1 March 2001 (2001-03-01), pages 310 - 321, XP001179875, ISSN: 0022-3549, DOI: 10.1002/1520-6017(200103)90:3<310::AID-JPS6>3.0.CO;2-R (B1)

CLELAND J L ET AL: "A SPECIFIC MOLAR RATIO OF STABILIZER TO PROTEIN IS REQUIRED FOR STORAGE STABILITY OF A LYOPHILIZED MONOCLONAL ANTIBODY", JOURNAL OF PHARMACEUTICAL SCIENCES, WILEY, vol. 90, no. 3, 1 March 2001 (2001-03-01), pages 310 - 321, XP001179875, ISSN: 0022-3549, DOI: 10.1002/1520-6017(200103)90:3<310::AID-JPS6>3.0.CO;2-R (B1)

EDWARD V LOFTUS: "New Data on the Use of Biologic Agents for Crohn's Disease and Ulcerative Colitis: Highlights from the 2009 CCFA Advances in IBD Meeting A Review of Selected Presentations from the 2009 Advances in Inflammatory Bowel Diseases/Crohn's & Colitis Foundation's With commentary by: A CME Activity Approved", 1 January 2009 (2009-01-01), XP055513757, Retrieved from the Internet <URL:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2886462/pdf/GH-06-S3-4.pdf> [retrieved on 20181008] (B1)

FEAGAN B G ET AL: "TREATMENT OF ULCERATIVE COLITIS WITH A HUMANIZED ANTIBODY TO THE ALPHA4BETA7 INTEGRIN", NEW ENGLAND JOURNAL OF MEDICINE, THE - NEJM, MASSACHUSETTS MEDICAL SOCIETY, US, vol. 352, no. 24, 1 June 2005 (2005-06-01), pages 2499 - 2507, XP009067914, ISSN: 1533-4406, DOI: 10.1056/NEJMOA042982 (B1)

WO-A2-98/06248 (B1)

PARIKH A ET AL: "1008 No Increase in JC Viremia, Lymphocyte Count, or Circulating CD34+ Hematopoietic Progenitor Cells After Treatment With Vedolizumab, a Humanized Monoclonal Antibody to +/-4^27 Integrin", GASTROENTEROLOGY, ELSEVIER INC, US, vol. 138, no. 5, 1 May 2010 (2010-05-01), pages S - 145, XP027023193, ISSN: 0016-5085, [retrieved on 20100427] (B1)

REICHERT JANICE M.: "Antibodies to watch in 2010", MABS, vol. 2, no. 1, 1 January 2010 (2010-01-01), US, pages 84 - 100, XP055861985, ISSN: 1942-0862, DOI: 10.4161/mabs.2.1.10677 (B1)

US-A1- 2007 122 404 (B1)

WO-A2-01/78779 (B1)

WO-A2-2006/026759 (B1)

LINDSAY: "Open-label study of MLN0002 in Ulcerative Colitis & Crohn's Disease - Health Research Authority", 26 March 2010 (2010-03-26), XP093035373, Retrieved from the Internet <URL:https://www.hra.nhs.uk/planning-and-improving-research/application-summaries/research-summaries/open-label-study-of-mln0002-in-ulcerative-colitis-crohns-disease/> (B1)